AMESITE INC (AMST)

US0310942042 - Common Stock

3.45  -0.05 (-1.43%)

Fundamental Rating

3

AMST gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 65 industry peers in the Diversified Consumer Services industry. No worries on liquidiy or solvency for AMST as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, AMST is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

In the past year AMST has reported negative net income.
In the past year AMST has reported a negative cash flow from operations.
AMST had negative earnings in each of the past 5 years.
In the past 5 years AMST always reported negative operating cash flow.

1.2 Ratios

AMST has a Return On Assets of -80.76%. This is amonst the worse of the industry: AMST underperforms 93.75% of its industry peers.
AMST has a worse Return On Equity (-84.00%) than 71.88% of its industry peers.
Industry RankSector Rank
ROA -80.76%
ROE -84%
ROIC N/A
ROA(3y)-86.75%
ROA(5y)-102.83%
ROE(3y)-92.76%
ROE(5y)-126.28%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AMST does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

AMST does not have a ROIC to compare to the WACC, probably because it is not profitable.
AMST has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AMST has been increased compared to 5 years ago.
AMST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

AMST has an Altman-Z score of 17.76. This indicates that AMST is financially healthy and has little risk of bankruptcy at the moment.
AMST's Altman-Z score of 17.76 is amongst the best of the industry. AMST outperforms 96.88% of its industry peers.
There is no outstanding debt for AMST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 17.76
ROIC/WACCN/A
WACC9.29%

2.3 Liquidity

A Current Ratio of 21.92 indicates that AMST has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 21.92, AMST belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 21.92 indicates that AMST has no problem at all paying its short term obligations.
AMST's Quick ratio of 21.92 is amongst the best of the industry. AMST outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 21.92
Quick Ratio 21.92

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 52.10% over the past year.
AMST shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -52.27%.
The Revenue has been growing by 141.97% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)52.1%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-27.21%
Revenue 1Y (TTM)-52.27%
Revenue growth 3Y141.97%
Revenue growth 5YN/A
Revenue growth Q2Q-82.73%

3.2 Future

The Earnings Per Share is expected to decrease by -20.40% on average over the next years. This is quite bad
Based on estimates for the next years, AMST will show a very strong growth in Revenue. The Revenue will grow by 148.15% on average per year.
EPS Next Y-44.97%
EPS Next 2Y-20.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year146.31%
Revenue Next 2Y148.15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMST. In the last year negative earnings were reported.
Also next year AMST is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as AMST's earnings are expected to decrease with -20.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.4%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AMST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMESITE INC

NASDAQ:AMST (4/26/2024, 1:34:03 PM)

3.45

-0.05 (-1.43%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.76M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -80.76%
ROE -84%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 21.92
Quick Ratio 21.92
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)52.1%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-44.97%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-52.27%
Revenue growth 3Y141.97%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y